Emerging technologies in cardiovascular medicine continue to shape the landscape of patient care. Artificial intelligence (AI) and machine learning algorithms are increasingly integrated into cardiovascular technologies to analyze complex datasets, enhance diagnostic accuracy, and predict patient outcomes. Telemedicine platforms offer remote consultations and monitoring, improving access to specialized cardiovascular care, particularly in underserved or remote areas. 3D printing technology is utilized to create patient-specific models for surgical planning, allowing for more precise interventions. Bioengineering innovations, such as tissue-engineered heart valves and regenerative therapies, hold promise for addressing the limitations of current treatment modalities. As cardiovascular technologies evolve, the field is poised for continued advancements, with a focus on personalized medicine, improved patient outcomes, and the overall optimization of cardiovascular health.
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain
Title : Innovative mechanisms, consequences and therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Comprehensive surgical revascularization for rapidly worsening ischemic heart failure
Deepak Puri, Max Healthcare, India